Bleeding and Clotting

Bleeding and Clotting Disorders   Protocol:CSL627_3001   Condition or Disease: Hemophilia A   Study Type: Interventional (Clinical Trial)   Status: Open for enrollment   Study Title: A Phase III Open Label, Multicenter, Extension Study to Assess the Safety and Efficacy of Recombinant Coagulation Factor VIII (rVIII SingleChain, CSL627) in Subjects with Severe Hemophilia A  

  Protocol:PRO15070638   Condition or Disease: Von Willebrand disease (vWD)   Study Type: Interventional (Clinical Trial)   Status: Opening Late 2018   Study Title: The VWD Minimize Menorrhagia (VWDMin) Trial     Principal I investigator: Joseph Lasky III, MD        

Bleeding and Clotting Disorders   Protocol:ALN-AT3SC-003   Condition or Disease: Hemophilia A or B   Study Type: Interventional (Clinical Trial)   Status: Open for enrollment   Study Title: ATLAS-INH: A Phase 3 Study to Evaluate the Efficacy and Safety of Fitusiran in Patients with Hemophilia A or B, with Inhibitory Antibodies to Factor VIII or

Bleeding and Clotting Disorders   Protocol:ALN-AT3SC-004   Condition or Disease: Hemophilia A or B   Study Type: Interventional (Clinical Trial)   Status: Open for enrollment   Study Title: ATLAS-A/B: A Phase 3 Study to Evaluate the Efficacy and Safety of Fitusiran in Patients With Hemophilia A or B, Without Inhibitory Antibodies to Factor VIII or

Bleeding and Clotting Disorders   Protocol:1160.106   Condition or Disease: Venous thrombosis   Study Type: Interventional (Clinical Trial)   Status: Open for enrollment   Study Title: Open-label, randomized, parallel-group, active-controlled, multi-centre, non-inferiority study of dabigatran etexilate versus standard of care for venous thromboembolism treatment in children from birth to less than 18 years of age:

Bleeding and Clotting Disorders   Protocol:1160.108   Condition or Disease: Venous Thromboembolism, Secondary Prevention   Study Type: Interventional (Clinical Trial)   Status: Open for enrollment   Study Title: Open label, single arm safety prospective cohort study of dabigatran etexilate for secondary prevention of venous thromboembolism in children from 0 to less than 18 years  

Bleeding and Clotting Disorders   Protocol:1321.7   Condition or Disease: Hemorrhage   Study Type: Interventional (Clinical Trial)   Status: Open for enrollment   Study Title: Single dose, open label, uncontrolled, safety trial of intravenous administration of idarucizumab to paediatric patients enrolled from ongoing phase IIb/III clinical trials with dabigatran etexilate for the treatment and secondary

Bleeding and Clotting Disorders   Protocol:GENA-99   Condition or Disease: Hemophilia A   Study Type: Observational   Status: Open for enrollment   Study Title: Prospective, multinational, non-interventional post-authorisation study to document the long-term immunogenicity, safety, and efficacy of Human-cl rhFVIII (simoctocog alfa) in patients with haemophilia A treated in routine clinical practice     Principal